Promoting Resilience in Stress Management for Adolescents With Type 1 Diabetes
JAMA Network Open · 19.08.2024 · 7 (8) · e2428287
DOI: 10.1001/jamanetworkopen.2024.28287 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift JAMA Network Open, online erschienen am 19.08.2024. Verfasst von Joyce P Yi-Frazier und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical & Translational Research, Seattle Children's Research Institute, Seattle, Washington. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Glycated Hemoglobin, Quality of Life, Resilience, Psychological. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Importance Type 1 diabetes (T1D) requires demanding self-management health behaviors, and adolescents with T1D are at risk for poor psychosocial and medical outcomes. Developing resilience skills may help adolescents with T1D and elevated distress navigate common stressors and achieve positive outcomes.
Objective
To test the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention on levels of hemoglobin A 1c (HbA 1c ), diabetes distress, self-management behaviors, resilience, and quality of life among adolescents. Design, Setting, and Participants This phase 3, parallel, 1:1 randomized clinical trial that followed up 172 participants for 12 months was conducted from January 1, 2020, to November 30, 2022, at each of 2 children’s hospitals, in Seattle, Washington, and Houston, Texas. Participants were ages 13 to 18 years with T1D for at least 12 months and elevated diabetes distress.
Intervention
PRISM, a manualized, skills-based, individual intervention program that teaches stress management, goal setting, reframing, and meaning-making, facilitated by a coach and accompanied by a digital app, was delivered in three 30- to 60-minute sessions approximately 2 weeks apart. Main Outcomes and Measures The 2 primary outcomes, diabetes distress and HbA 1c levels, and 3 secondary outcomes, resilience, quality of life, and engagement in self-management behaviors, were assessed at baseline and 6 and 12 months after baseline. Linear mixed-effects regression models were used to evaluate associations between PRISM or usual care (UC) and these outcomes at both time points for the intention-to-treat population.
Results
Among 172 adolescents (mean [SD] age, 15.7 [1.6] years), 96 were female (56%), and their baseline mean (SD) HbA 1c level was 8.7% (2.0%). No differences were evident between PRISM and UC recipients in HbA 1c levels (β, −0.21 [95% CI, −0.65 to 0.22]; P = .33) or diabetes distress (β, −2.71 [95% CI, −6.31 to 0.90]; P = .14) or any participant-reported outcome (eg, β, 2.25 [95% CI, −0.30 to 4.80]; P = .08 for self-management behaviors) at 6 months. At 12 months, there was no statistically significant difference between arms in HbA 1c levels (β, −0.26 [95% CI, −0.72 to 0.19]; P = .25); however, PRISM recipients reported significantly greater amelioration of diabetes distress (β, −4.59 [95% CI, −8.25 to −0.94]; P = .01) and improvement in self-management behaviors (β, 3.4 [95% CI, 0.9 to 5.9]; P = .01) compared with UC recipients. Conclusions and Relevance The findings in this randomized clinical trial of psychosocial and behavioral improvements associated with PRISM at 12 months illustrate the value of a strengths-based intervention. Integrating resilience skills-building with traditional diabetes care may be a promising approach for improving outcomes among adolescents with T1D and elevated diabetes distress. Trial Registration ClinicalTrials.gov number: NCT03847194
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Clinical & Translational Research, Seattle Children's Research Institute, Seattle, Washington.
- Department of Psychosocial Oncology & Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.
- Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston.
- Cambia Palliative Care Center of Excellence, University of Washington School of Medicine, Seattle.
- Center for Child Health, Behavior, and Development, Seattle Children's Research Institute, Seattle, Washington.
- Division of General Pediatrics, Department of Pediatrics, University of Washington School of Medicine, Seattle.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Yi-Frazier, J. P., Hilliard, M. E., O'Donnell, M. B., Zhou, C., Ellisor, B. M., Garcia Perez, S., Duran, B., Rojas, Y., Malik, F. S., DeSalvo, D. J., Pihoker, C., Bradford, M. C., Scott, S., Devaraj, S., & Rosenberg, A. R. (2024). Promoting Resilience in Stress Management for Adolescents With Type 1 Diabetes. JAMA Network Open, 7(8), e2428287. https://doi.org/10.1001/jamanetworkopen.2024.28287
Vancouver
Yi-Frazier JP, Hilliard ME, O'Donnell MB, Zhou C, Ellisor BM, Garcia Perez S, et al. Promoting Resilience in Stress Management for Adolescents With Type 1 Diabetes. JAMA Network Open. 2024;7(8):e2428287. doi:10.1001/jamanetworkopen.2024.28287
BibTeX
@article{YiFrazier2024,
author = {Yi-Frazier, Joyce P and Hilliard, Marisa E and O'Donnell, Maeve B and Zhou, Chuan and Ellisor, Britney M and Garcia Perez, Samantha and Duran, Brenda and Rojas, Yuliana and Malik, Faisal S and DeSalvo, Daniel J and Pihoker, Catherine and Bradford, Miranda C and Scott, Samantha and Devaraj, Sridevi and Rosenberg, Abby R},
title = {Promoting Resilience in Stress Management for Adolescents With Type 1 Diabetes},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {8},
pages = {e2428287},
doi = {10.1001/jamanetworkopen.2024.28287}
}
EUVIMED